The staying power of technology after the pandemic The clinical trials industry has historically been slow to adopt innovation, but 2020 was a catalyst for transformation. Spurred on by the need for business continuity during the pandemic, sites and sponsors worldwide were highly motivated to reconsider business as usual, and many have adopted an array...
We recently passed Crohn’s and Ulcerative Colitis Awareness Week (December 1-7, 2020) and Clinical Research IO was interested in learning more about clinical research in gastroenterology. We connected with Gerry Glazer, Henika Lobo, and Dr. Michael Gould of TDDA Specialty Research (TDDA) to gain insight into conducting GI research. Can you tell us how TDDA...
If you’re considering new software for your site, you’ll need a game plan. Technology is designed to make your work-life easier, but with so many options, the search for the right solution can quickly become frustrating. To start, make a list of the challenges that you would like your new solution to address, and separate...
Are you interested in investing in clinical trial software at your research site, but worried how your staff will adapt to the change? At Team CRIO, we partner with many sites who experience this challenge; that’s why we ensure you’ll have a dedicated project manager for your team. In this webinar, Luke Snedaker, the VP...
Achieving representative enrollment – meaning diversity in race, age, gender and socioeconomic status – in clinical trials is essential to the development of cutting-edge therapies for the general population. Despite being recognized as a need within the industry, it has proven to be a longstanding challenge. According to the 2019 ‘Drugs Trials Snapshots’ report released...
COVID-19 trials have quickly become the top trafficked listings. According to WCG Insights, COVID trial listings represent 15.1% of total visits in the last 6 months and has led to a decrease in interest in trials for other conditions. Given the fluid nature of the pandemic and the increasing need for COVID treatments and vaccines,...
Clinical research coordinators (CRCs) shoulder significant responsibility in the conduct of clinical trials — seeing back-to-back patients, processing labs, completing data entry, responding to emails, liaising with monitors — and play an incredibly important part in the research process. As clinical trial complexity increases and more emphasis is placed on data quality, the demand for...
Dr. James Clark of Charlottesville Medical Research recently had an FDA inspection of his site as it is a high enroller. He did not receive a FDA Form 483, and he was using the CRIO electronic source system on the study. Learn about his experience in this Q&A session. CRIO: What’s your background? Dr. Clark:...
At the beginning of May 2020, many of the larger pharmaceutical companies released their first quarter financials and shared their plans to open up research amid the ongoing coronavirus crisis. Determined to return to near normal operations by the end of the year, sponsors said they would begin to lift enrollment holds and initiate new studies. According...
According to the latest survey by Clinical Research IO, clinical trials have largely re-opened. While we should remain optimistic about the restart, Dr. Lindsay McNair, Chief Medical Officer of WCG, reminds us that “we are not post-COVID in many ways.” Given that clinical trials will have to take place amid the ongoing pandemic, “we should...
How did you get into research? I got started in clinical research as an undergrad. There was a group of physicians from Harvard that came to the University of Cincinnati, where I was studying, who started a centralized research office. I was part of that team. The first 2 years I coordinated, and my last...
Creating exceptional clinical research source documents is crucial for successful clinical trials. The best way to ensure that your source documents are ready is to know and understand the Clinical Study Protocol (CSP), which serves as the basis for your source documents. Use the CSP as your primary reference when creating source documents. This is...
